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ABSTRACT
By site-directed mutagenesis we have changed the serine
residue 232 of the ,29 terminal protein, involved in the covalent
linkage to dAMP for the initiation of replication, into a threo-
nine residue. The mutant terminal protein has been purified to
homogeneity and shown to be inactive in the formation of the
initiation complex; nevertheless, the mutant protein retains its
ability to interact with the 029 DNA polymerase and with the DNA.
The results obtained indicate a high specificity in the linking
site of the terminal protein.
INTRODUCTION
B. subtilis phage ,Y29 has a linear, double-stranded DNA of
19,285 base pairs (1-3) with a viral terminal protein, p3, cova-
lently linked to the two 5'ends through a phosphodiester bond
between the OH group of serine residue 232 and dAMP (4). The
viral genome replicates by a strand-displacement mechanism
starting from either end (reviewed in 5), in which the free ter-
minal protein plays a crucial role priming the initiation reac-
tion by formation of a covalent complex with 5'dAMP catalyzed by
the viral DNA polymerase p2 (6,7). An in vitro system has been
developed for the formation of the initiation complex in which
purified proteins p2 and p3, and 029 DNA-protein p3 complex as
template are the only macromolecular requirements (6,7).
Furthermore, in this system the initiation complex can be elon-
gated to full-length r29 DNA (8). Addition of NH4+ ions and viral
protein p6 to the in vitro system stimulate 929 DNA replication
(8-11).
The formation of the initiation complex p3-dAMP is accom-
plished by interaction of a free molecule of the terminal protein
with the viral DNA polymerase (11) and the recognition of the
origins of replication, mainly by interaction with the terminal
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protein covalently attached to the 5' ends of the template.
Initiation can also occur in a lesser extent with protein-free
templates containing at least the terminal 12 base pairs of
either 929 DNA end (12-14).
By site-directed mutagenesis we are changing different amino
acid residues in the terminal protein to correlate the structure
with the function of the protein, by studying the formation of
the initiation complex, and the interaction with the DNA polyme-
rase and the DNA. In this paper we address the question of the
specificity of the linking site by changing the serine residue
232, the donor of the OH group in the phosphodiester linkage with
the first nucleotide, by a threonine residue, that would be the
minimal structural replacement able to form that linkage. In
fact, the Streptococcus pneunoniae phage Cp-1 terminal protein is
linked to the DNA through a phosphothreonine bond (15). We show
here that the Ser2324Thr change completely abolishes the priming
function of the 929 terminal protein.
MATERIALS AND METHODS
Plasmids, bacteria and phages
Restriction fragments containing the 929 gene 3 truncated at
the carboxyl end were obtained from plasmid pRMtl2l (16). The
complete gene was obtained from plasmid pRMn25 (17) and the gene
3 expression vector was derived from plasmid pPLc28 (18),
obtained from E. Remaut.
E. coli strain Alacpro, supE, thi, strA, sbcB15, endA,
hspR4, F' traD36, proAB, lacIqZAM15, also called JM103 (19) was
a gift from Antibi6ticos S.A. and used as a host of M13-derived
vectors, and E. coli strain M72 SmRlacZam Abio-uvrBAtrpEA2 (XNam7
Nam53cI857AH1), here designated K-12AHlAtrp (20), was obtained
from M. Zabeau and used as host of expression vectors derived
from pPLc28.
Phage M13mp8 replicative form (21) used to perform the site-
directed mutagenesis was a gift from Antibi6ticos S.A.
Enzymes and chemicals
Restriction enzymes, T4 polynucleotide ligase and Klenow
fragment of E. coli DNA polymerase I were from Boehringer
Mannheim, IPTG and X-gal from Sigma, deoxynucleoside triphospha-
and dideoxynucleoside triphosphates from PL Biochemicals.
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Sequencing primer, 35S-methionine (1000 Ci/mmol), [y-32PATP
(-3000 Ci/mmol), [ 35S]dATPxS(-600 Ci/mmol) and [-32P] dATP (-410
Ci/mmol) were from Amersham International, plc. The synthetic
oligonucleotide used in the site-directed mutagenesis was a gift
from Antibioticos S.A., and further purified by gel filtration
through a Sephadex G-50 column and electrophoresis in a 15%
polyacrylamide gel containing 8.3 M urea. Prior to use, the
oligonucleotide was phosphorylated with T4 polynucleotide kinase
as described (22) and sequenced by the Maxam and Gilbert method
(23).
DNA manipulations
Plasmids were isolated as described (24) except for analy-
tical purposes where the alkaline lysis method (25) was followed.
Restriction enzymes were used as recommended by the supplier.
Ligation of restriction fragments, filling-in of cohesive ends
with the Klenow fragment, and analytical agarose gel electropho-
resis were as described (26). Purification of restriction frag-
ments was done by electrophoresis in low melting agarose gels
(27). E. coli K-12AHlAtrp cells were made competent and trans-
formed as described (28).
Site-directed mutagenesis in phage 929 gene 3
Plasmid pRMtl2l (16), derived from pPLc28 (18), contains the
929 DNA HindIII G fragment, coding for protein p3, except for the
last five amino acids at the carboxyl end. The EcoRI-BamHI frag-
ment, containing the 929 HindIII G fragment, was isolated and
inserted into the corresponding targets of the polycloning site
of the replicative form of phage M13mp8. E. coli JM103 cells were
transformed, and single-stranded DNA from white plaques was used
as template for site-directed mutagenesis performed by the method
of Zoller and Smith (22). One pmol of single-stranded -DNA was
hybridized with 30 molar excess of a 18-mer synthetic oligonu-
cleotide complementary to the gene 3 region containing the Ser232
codon AGT in a central position, with a G:G mismatch to give rise
to the threonine codon ACT. After primer extension, the
covalently closed circular DNA was isolated in a 5 to 20% linear
sucrose gradient in 1 M NaCl, 0.2 M NaOH and 2 mM EDTA,
centrifuged at 100,000 x g during 100 min and used directly to
transform E. coli JM103 cells. Phage obtained from 46 plaques
was used directly in a dot-blot test (22). Two putative mutants
5729
Nucleic Acids Research
were grown in E. coli JM103 cells, replated and the dot-blot test
was performed once again with phage from isolated plaques. The
presence of the mutation was confirmed by sequencing by the chain
termination method with [35 ]dATP (29) using an universal primer.
The recombinant phage was named M13mp8.3T232AC.
Purification of mutant Ser2324Thr of the 029 terminal protein
Mutant terminal protein was purified from E. coli
K-12AHlAtrp cells transformed with plasmid p3T232. The cells were
grown at 300C until mid-log phase, the temperature was raised to
420C to allow induction and the cells were further grown for two
hours. The purification procedure was based in the method descri-
bed for the wild-type protein (30). Cell extract was obtained by
grinding 12 g of cells with alumina and resuspension with 60 ml
of buffer A (20 mM Tris-HCl, pH 7.5, 25 mM NaCl, 1 mM EDTA, 7 mM
1-mercaptoethanol and 5% glycerol). Alumina and debris were remo-
ved by centrifugation for 10 min at 20,000 x g. The extract was
passed through a DEAE-cellulose column (100 ml) equilibrated in
buffer A containing 0.3 M NaCl, washed thoroughly with the same
buffer and protein p3 was eluted with buffer A containing 0.7 M
NaCl. Contaminant nucleic acids were removed by precipitation
with 0.2% polyethyleneimine in the presence of 1 M NaCl. The
supernatant was precipitated with 65% (NH4)2 SO4 in the presence
of bovine serum albumin as carrier and the pellet was resuspended
in 2 ml of 20 mM Tris-HCl, pH 7.5, 20% glycerol and passed
through a phosphocellulose column (0.4 ml) equilibrated in buffer
B (20 mM Tris-HCl, pH 7.5, 0.25 M NaCl), washed with the same
buffer and protein p3 was eluted with buffer B containing 1 M
NaCl and 0.002% Nonidet P-40. The sample was diluted up to 50 mM
NaCl with buffer A without NaCl, passed through a second DEAE-
cellulose column (0.5 ml) equilibrated in buffer A containing 50
mM NaCl and washed with the same buffer; protein p3 was eluted
with buffer A containing 0.1 M NaCl, and concentrated in a phos-
phocellulose column (0.1 ml) equilibrated in buffer B, and eluted
with buffer B containing 1 M NaCl. Mutant protein p3 along the
purification steps was identified by radioimmunoassay (30) using
antibody against wild-type protein p3. The protein in the dif-
ferent steps was analyzed by SDS-polyacrylamide gel electropho-
resis as described (30). The purified protein did not contain
contaminating nucleases.
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Figure 1. Construction of a recombinant expression plasmid con-
taining the mutation Ser 4Thr in $29 gene 3. The EcoRI-BamHI
fragment from plasmid pRAAi5, containing $29 gene 3, was inserted
in the expression vector pPLc28 after removal of the HindllI
restriction site, giving rise to plasmid p3S 2' in which the $29
gene 3 is transcribed under the control of ti phage X P promo-
ter. The direction of transcription is indicated by an airow. The
HindIII fragment from plasmid p3S , containing gene 3 with a
deletion at the carboxyl terminus, as replaced by the correspon-
ding fragment from the replicative form of phage M13mp8.3T AC
that contains the mutation Ser 4Thr obtained by site-dir2ied
mutagenesis. gene 3,ok*geAe 3 with the mutation Ser2324Thr;
the arrow head indicates the carboxyl end.
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Assay for the formation of the initiation complex
The reaction mixture contained, in 25 pl, 50 mM Tris-HCl, pH
7.5, 10 mM MgCl2, 1 mM DTT, 1 mM spermidine, 20 mM (NH4)2so4,
0.25 pM [a- P]dATP (2 pCi), 0.5 pg of 929 DNA-protein p3 templa-
te (31), 19 ng of purified protein p2 (6), 2 pg of purified
protein p6 (9) and 15 ng of purified wild-type (30) or mutant
protein p3. After incubation at 30°C for the indicated times, the
reaction was stopped by addition of EDTA to 12.5 mM and heating
for 10 min at 680C and the samples were processed as described
(10).
RESULTS AND DISCUSSION
Expression of the Ser232-+Thr mutant of bacteriophage 929 terminal
protein
The strategy followed to clone the mutant gene 3 in an
expression vector to overproduce the protein is shown in Fig. 1.
The EcoRI-BamHI fragment from plasmid pRMn25 (17) containing 029
gene 3 was inserted under the control of the X PL promoter in the
expression vector pPLc28 (18) in which the unique HindIII site
was removed by digestion with HindIII and ligation after filling-
in the cohesive ends. By transformation of E. coli K-126Hl6trp
cells, plasmid p3S232 was obtained. The 929 HindIII G fragment
containing the mutation was obtained from the replicative form of
M13mp8.3T232 6C (see Materials and Methods), and used to replace
the corresponding wild-type fragment from plasmid p3S232. The
recombinant plasmid containing the mutant gene 3 in the correct
orientation was named p3T232. Figure 2 shows the presence of the
G4C transversion in the HindIII fragment from plasmid p3T232
inserted in the replicative form of M13mp8 and sequenced as
indicated before (29).
Synthesis of 35S-labelled protein p3 by E. coli K-12AHlAtrp
cells harbouring plasmids p3S232 and p3T232 is shown in Figure 3.
A protein band with the same electrophoretic mobility as the 929
terminal protein appeared in cells transformed by plasmids p3S232
or p3T232 after 1 h or 2 h of induction at 420C, but not in the
cells kept at 300C. This protein was synthesized to a similar
extent at least after 3 h of induction. Two other polypeptides
were induced; one of them corresponds by its electrophoretical
mobility to the viral protein p4 encoded in the cloned HindIII G
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Figure 2. Sequence of the Ser4Thr mutant at position 232 of the
R29 terminal protein. The HindIII fragment from plasmid p3S232,
containing the truncated wild-type gene 3, or plasmid p3T 3,,
with the truncated mutant gene 3 (see Fig. 1), were clone8 n the
replicative form of phage M13mp8 and sequenced by the chain ter-
mination method (29). The sequence shows the complementary strand
of the Ser codon AGT in the wild-type (a) and of the correspon-
ding Thr codon ACT in the mutant (b) gene 3.15.
fragment (16); the other one could be also encoded by the same
fragment and affected by the mutation since there is a different
electrophoretic mobility between the wild-type and the mutant
peptides (Fig. 3 lanes c and d, g and h). These two polypeptides
also appear in induced cells containing plasmid pRMn25 (17).
Extracts were prepared from E. coli K-12AHlAtrp cells
containing plasmid p3T232 or p3S232, and the presence of protein
p3 detected by radioimmunoassay; no difference was observed
between them (not shown). The extracts were also assayed for
their activity in the formation of the initiation complex by com-
plementation with purified 029 DNA polymerase, purified protein
p6 and 929 DNA-protein p3 as template. Formation of p3-dAMP ini-
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Figure 3. Induced synthesis of the wild-type terminal protein or
the Ser.,3.,Thr mutant by plasmids p35 and p3T 2,., Bacterialculture§l arbouring plasmids p35.,3 (*AAes a, c, ;~~nd g) orp3T22, (lanes b, d, £ and h) were irown in L broth at 300C until
mid-Ib phase and the cells were harvested and resuspended in an
equal volume of minimal medium; half of the cultures were further
grown at 300C (lanes a, b, e and f) and the other half at 420C
(lanes c, d, 3g3nd h) for 60 min (a-d) or 120 min (lanes e-h),labelled with S-methionine for 10 min and subjected to 5DS-
polyacrylamide gel electrophoresis as described (16). The mobili-
ty of proteins p3 and p4 are indicated.
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Figure 4. SDS-polyacrylamide gel electrophoresis of the purifica-
tion steps of the Ser 4Thr mutant of the %29 terminal protein.
Proteins at various p&i?fication steps were subjected to SDS-gel
electrophoresis in a 10-20% acrylamide gradient. Lanes: a, ex-
tract (50 ,ug); b, protein eluted at 0.7 M NaCl from a DEAE-cel-
lulose column; nucleic acid was removed by polyethyleneimine
precipitation and protein was concentrated by ammonium sulfate
precipitation (7.5 ug); c, protein eluted from a phosphocellulose
column with 1 M NaCl (4.3 ug); d, protein eluted from the second
DEAE-cellulose column at 0.3 M NaCl (1.3 1g).
tiation complex was observed in extracts from cells containing
plasmid p3S232, but not in those with plasmid p3T232 (not shown),
suggesting that the mutation Ser2324Thr inactivates the terminal
protein for the priming reaction.
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Figure 5. Formation of the initiation complex with the wild-type
terminal protein and the Ser, 2Thr mutant. The reaction mixture
was incubated for 5 min in ti; conditions described in Materials
and Methods. Lanes: a, wild-type protein alone; b, mutant protein
alone; c, wild-type protein added at 0 min and mutant protein
added at 2.5 min; d, mutant protein added at 0 min and wild-type
protein added at 2.5 min; e, wild-type protein alone added at 2.5
min.
Purification and properties of mutant Ser2324Thr of the 929 ter-
minal protein
To further study the activity of the mutant protein, it was
purified to homogeneity based on the method developed to purify
the wild-type terminal protein (30). No differences were observed
between the two proteins along the purification procedure; mutant
protein p3 also eluted at 0.7 M NaCl from a DEAE-cellulose column
together with nucleic acids, while most of the protein contami-
nants present in the extract eluted at 0.3 M NaCl. Fig. 4 shows
the analysis by SDS-polyacrylamide gel electrophoresis of the
purification steps of the mutant protein p3.
Purified protein p3 containing the mutation Ser2324Thr did
not show any activity in the formation of the initiation complex
(Fig. 5, lane b), even in conditions in which less than 0.1% of
the wild-type activity could have been detected. On the other
hand, the amount of initiation complex formed in 5 min with the
wild-type protein alone (Fig. 5, lane a) was higher than that
obtained when the mutant protein was added after 2.5 min (Fig. 5,
lane c). In addition, the amount of p3-dAMP complex formed in 2.5
min with the wild-type protein (Fig. 5, lane e) was much higher
than that obtained when the mutant protein was previously added
(Fig. 5, lane d). When both proteins were added at the same time,
the initiation complex formed was about half of that formed by
the wild-type protein alone (not shown). These results suggest
that the mutant terminal protein competes with the wild-type
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Figure 6. Interaction of the wild-type terminal protein and the
Ser-oThr mutant with the th29DNA polymerase. Wild-type terminal
prot An (0.6T ig) or Sera o Thr mutant (0.6t ig) was incubated with
0.6 pg of %29 DNApolymense for 1 h at 0oC in a final volume of
0.2 ml in a buffer containing 50 mM Tris-HC1, pH 7.5, 44 mM NaCl
and 20 mM (NH4) ,soA The samples were layered on top of a 5 ml
linear 15 30% iycrol gradient in the above buffer and centri-
fuged for 28 h at 290,000 x g at 40C. Fractions were collected
from the bottom and terminal proteins and DNA polymerase were
detected by radioimmunoassay (RIA) as described (30). A, wild-
type terminal protein. B, mutant terminal protein. Sedimentation
was from right to left.
protein in the interaction with the DNA polymerase and/or with
the DNA. The interaction between the terminal protein and the JY29
DNA polymerase, in the presence of NH + ions, can be detected by
glycerol gradient centrifugation (11). The formation of such a
complex with the mutant terminal protein was studied to determine
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Figure 7. Interaction of the wild-type terminal protein and the
Ser 4Thr mutant with DNA. Wild-type terminal protein (0.6 pg)
or i 3 Thr mutant (0.6 ug) was incubated with 20 pg of $29 DNA
for 1 iit 0°C in a final volume of 0.2 ml in the buffer descri-
bed in the legend to Fig. 6 containing 1 mM EDTA, and subjected
to glycerol gradient centrifugation for 4 h at 260,000 x g as
described in the legend to Fig. 6. Fractions were collected from
the bottom. The position of DNA, indicated by an arrow, was
determined by agarose gel electrophoresis and ethidium bromide
staining. The terminal protein was detected by radioimmunoassay
as described (30). A, wild-type terminal protein. B, Ser232-Thr
mutant. Sedimentation was from right to left.
whether the Ser232+Thr mutation affects the site of interaction
with the DNA polymerase. Fig. 6 shows that the mutant terminal
protein interacts with the $29 DNA polymerase in the same extent
as the wild-type protein.
The phage 029 terminal protein or its complex with the DNA
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polymerase must recognize the terminal sequences of 929 DNA since
the initiation complex can be formed in protein-free templates
containing at least the 12 base pairs of the i29 DNA ends (14).
However, no specific interaction of the terminal protein, by
itself or in the presence of the DNA polymerase, with 029 DNA
terminal fragments has been obtained so far. Instead, unspecific
interaction of protein p3 with double-stranded DNA has been
obtained (32). Figure 7 shows that the Ser2324Thr mutant of
protein p3 cosediments with DNA in a glycerol gradient in a way
similar to that of the wild-type protein.
The results presented here indicate that the priming residue
of the 029 terminal protein is highly specific and the mutation
Ser232-Thr seems to affect the ability of the P29 DNA polymerase
to catalyze the formation of the covalent complex with dAMP. It
would be interesting to find 029 DNA polymerase mutants able to
form the initiation complex with the mutant terminal protein.
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